Palisade Stock Analysis


USD 4.03  0.14  3.60%   

The current drop in stock price may encourage stockholders to take a closer look at the company as it is trading at a share price of 4.03 on 297,313 in trading volume. The company management teams have failed to build on market volatilities in November. However, diversifying your overall positions with Palisade Bio may protect your principal portfolio during upcoming market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 12.92. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Palisade Bio partners.
Please check Your Equity Center.
The Palisade Bio stock analysis report makes it easy to digest most publicly released information about Palisade Bio and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Palisade Stock analysis module also helps to analyze the Palisade Bio price relationship with some important fundamental indicators such as market cap and management efficiency.

Palisade Stock Analysis Notes

The company has price-to-book ratio of 0.47. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Palisade Bio recorded earning per share (EPS) of 11.66. The entity last dividend was issued on the 18th of July 2019. The firm had 1:50 split on the 16th of November 2022. Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. The company was founded in 2005 and is headquartered in Carlsbad, California. Palisade Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people. To find out more about Palisade Bio contact the company at 858 704 4900 or learn more at

Palisade Bio Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Palisade Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Palisade Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Palisade Bio generated a negative expected return over the last 90 days
Palisade Bio has high historical volatility and very poor performance
Net Loss for the year was (26.62 M) with profit before overhead, payroll, taxes, and interest of 0.
Palisade Bio currently holds about 5 M in cash with (14.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.

Palisade Market Capitalization

The company currently falls under 'Nano-Cap' category with current market capitalization of 6 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Palisade Bio's market, we take the total number of its shares issued and multiply it by Palisade Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (0.5797) % which means that it has lost $0.5797 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (1.158) %, meaning that it created substantial loss on money invested by shareholders. Palisade Bio management efficiency ratios could be used to measure how well palisade bio manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 1st of December, Palisade Bio holds the coefficient of variation of (2,017), and Risk Adjusted Performance of (0.06). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Palisade Bio, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Palisade Bio, which can be compared to its competitors. Please check Palisade Bio treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Palisade Bio is priced some-what accurately, providing market reflects its current price of 4.03 per share. Given that Palisade Bio has jensen alpha of (0.80), we recommend you to check out Palisade Bio's recent market performance to make sure the company can sustain itself at a future point.

Palisade Bio Price Movement Analysis

The output start index for this execution was eighteen with a total number of output elements of fourty-three. Palisade Bio Triple Exponential Moving Average indicator shows smoothing effect of Palisade Bio price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

Palisade Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Palisade Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Palisade Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Palisade Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Palisade Bio Predictive Daily Indicators

Palisade Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Palisade Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Palisade Bio Forecast Models

Palisade Bio time-series forecasting models is one of many Palisade Bio's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Palisade Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Palisade Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Palisade Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Palisade shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Palisade Bio. By using and applying Palisade Stock analysis, traders can create a robust methodology for identifying Palisade entry and exit points for their positions.
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. The company was founded in 2005 and is headquartered in Carlsbad, California. Palisade Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Palisade Bio to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Fundamental Analysis Now


Fundamental Analysis

View fundamental data based on most recent published financial statements
All  Next Launch Module
Please check Your Equity Center. You can also try Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for analysis

When running Palisade Bio price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Is Palisade Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
Return On Assets
Return On Equity
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Palisade Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.